Canepa Healthcare is a U.S. late-stage venture and growth-capital firm that invests in healthcare companies based in the United States and Europe. The firm was founded in 2014 and operates as a sector-specialist healthcare growth-equity and late-stage venture investor, targeting healthcare companies at Series C, D, and pre-IPO / crossover rounds. The firm was founded by Anthony J. Canepa (long-tenured healthcare investor previously in healthcare investment banking and principal-investing roles) alongside partners. Canepa Healthcare typically writes initial check sizes in the USD 10 to 50 million range as a growth investor into late-stage biopharma, medical-device, and healthcare-services companies. Detailed aggregate current-fund AUM, fund-vintage disclosures, and comprehensive portfolio-company disclosures are partially documented in mainstream financial-industry databases for this specific URL, consistent with the profile of a mid-size healthcare-specialist late-stage fund. The row should be noted as Active.